Page last updated: 2024-08-17

cycloheximide and silicon phthalocyanine pc4

cycloheximide has been researched along with silicon phthalocyanine pc4 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiu, SM; Mak, TW; Nagy, B; Separovic, D; Yeh, WC	1

Other Studies

1 other study(ies) available for cycloheximide and silicon phthalocyanine pc4

Article	Year
FADD null mouse embryonic fibroblasts undergo apoptosis after photosensitization with the silicon phthalocyanine Pc 4. Archives of biochemistry and biophysics, 2001, Jan-01, Volume: 385, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Carboxylic Acids; Carrier Proteins; Caspase 3; Caspases; Ceramides; Cycloheximide; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Activation; Fas-Associated Death Domain Protein; Fibroblasts; Fumonisins; In Situ Nick-End Labeling; Indoles; Light; Mice; Mice, Knockout; Models, Biological; Organosilicon Compounds; Oxidative Stress; Oxidoreductases; Oxygen; Photosensitizing Agents; Protein Synthesis Inhibitors; Silanes; Time Factors; Tumor Necrosis Factor-alpha	2001

Article

Year

FADD null mouse embryonic fibroblasts undergo apoptosis after photosensitization with the silicon phthalocyanine Pc 4.

Archives of biochemistry and biophysics, 2001, Jan-01, Volume: 385, Issue:1

Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Carboxylic Acids; Carrier Proteins; Caspase 3; Caspases; Ceramides; Cycloheximide; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enzyme Activation; Fas-Associated Death Domain Protein; Fibroblasts; Fumonisins; In Situ Nick-End Labeling; Indoles; Light; Mice; Mice, Knockout; Models, Biological; Organosilicon Compounds; Oxidative Stress; Oxidoreductases; Oxygen; Photosensitizing Agents; Protein Synthesis Inhibitors; Silanes; Time Factors; Tumor Necrosis Factor-alpha

2001